sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive statusAJOG Global Reports at a Glance

• Váldodahkkit: Easha Patel, MD (Dahkki), Sunitha Suresh, MD (Dahkki), Ariel Mueller, MA (Dahkki), Courtney Bisson, MD (Dahkki), Katherine Zhu, MD (Dahkki), Stefan Verlohren, MD, PhD (Dahkki), Peter Von Dadelszen, MBChB, DPhil (Dahkki), Laura Magee, MD (Dahkki), Sarosh Rana, MD, MPH (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2024-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

BACKGROUND: In high-resource settings, biomarkers of angiogenic balance, such as the soluble fms-like tyrosine kinase-1 (sFlt1)/placental growth factor (PlGF) ratio, have been studied extensively to aid in evaluation of patients with suspected preeclampsia (PE), and have been incorporated into the 2...